反应详情

Using [4-(5-cyclopropyl-3-methylpyridin-2-yl)piperazin-1-yl](2,4-dibromophenyl)methanone (250 mg) described in Preparation Example 238 and 1-acetylimidazolidin-2-one (200 mg) and by the reaction and treatment in the same manner as in Example 638, the title compound (102 mg) was obtained.